<?xml version="1.0" encoding="UTF-8"?>
<item version="1.00">
<basic id="7225">
<itemtype>xnppaper</itemtype>
<titles><title>Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction.</title>
</titles>
<contributor uname='admin'>DBPF Administrator 1(admin)</contributor>
<keywords><keyword>Acetylcholinesterase</keyword>
<keyword>metabolism</keyword>
<keyword>Aconitine</keyword>
<keyword>analogs</keyword>
<keyword>&amp;</keyword>
<keyword>derivatives</keyword>
<keyword>pharmacology</keyword>
<keyword>Animals</keyword>
<keyword>Animals</keyword>
<keyword>Newborn</keyword>
<keyword>Antibodies</keyword>
<keyword>Monoclonal</keyword>
<keyword>toxicity</keyword>
<keyword>Cholinergic Fibers</keyword>
<keyword>drug effects</keyword>
<keyword>physiology</keyword>
<keyword>radiation effects</keyword>
<keyword>Denervation</keyword>
<keyword>methods</keyword>
<keyword>Dihydro-beta-Erythroidine</keyword>
<keyword>pharmacology</keyword>
<keyword>Dose-Response Relationship</keyword>
<keyword>Drug</keyword>
<keyword>Dose-Response Relationship</keyword>
<keyword>Radiation</keyword>
<keyword>Electric Stimulation</keyword>
<keyword>methods</keyword>
<keyword>Excitatory Amino Acid Antagonists</keyword>
<keyword>pharmacology</keyword>
<keyword>GABA Antagonists</keyword>
<keyword>pharmacology</keyword>
<keyword>Hippocampus</keyword>
<keyword>cytology</keyword>
<keyword>drug effects</keyword>
<keyword>Immunohistochemistry</keyword>
<keyword>methods</keyword>
<keyword>Immunotoxins</keyword>
<keyword>toxicity</keyword>
<keyword>Long-Term Potentiation</keyword>
<keyword>drug effects</keyword>
<keyword>N-Glycosyl Hydrolases</keyword>
<keyword>Neural Inhibition</keyword>
<keyword>drug effects</keyword>
<keyword>physiology</keyword>
<keyword>radiation effects</keyword>
<keyword>Neurons</keyword>
<keyword>drug effects</keyword>
<keyword>physiology</keyword>
<keyword>Nicotine</keyword>
<keyword>pharmacology</keyword>
<keyword>Nicotinic Agonists</keyword>
<keyword>pharmacology</keyword>
<keyword>Nicotinic Antagonists</keyword>
<keyword>pharmacology</keyword>
<keyword>Patch-Clamp Techniques</keyword>
<keyword>methods</keyword>
<keyword>Phosphinic Acids</keyword>
<keyword>pharmacology</keyword>
<keyword>Picrotoxin</keyword>
<keyword>pharmacology</keyword>
<keyword>Propanolamines</keyword>
<keyword>pharmacology</keyword>
<keyword>Quinoxalines</keyword>
<keyword>pharmacology</keyword>
<keyword>Rats</keyword>
<keyword>Receptors</keyword>
<keyword>Nicotinic</keyword>
<keyword>physiology</keyword>
<keyword>Ribosome Inactivating Proteins</keyword>
<keyword>Type 1</keyword>
<keyword>Valine</keyword>
<keyword>analogs</keyword>
<keyword>&amp;</keyword>
<keyword>derivatives</keyword>
<keyword>pharmacology</keyword>
<keyword>gamma-Aminobutyric Acid</keyword>
<keyword>metabolism</keyword>
<keyword>pharmacology</keyword>
</keywords>
<description></description>
<doi></doi>
<last_update_date>2013-02-28T01:15:57Z</last_update_date>
<creation_date>2013-02-28T01:15:57Z</creation_date>
<publication_year>2005</publication_year>
<publication_month>0</publication_month>
<publication_mday>0</publication_mday>
<lang>eng</lang>
<url>https://dynamicbrain.neuroinf.jp/modules/xoonips/detail.php?item_id=7225</url>
<changelogs>
</changelogs>
<index></index>
</basic>
<detail id="7225" version="1.02">
<authors><author>Yamazaki Y</author><author>Jia Y</author><author>Hamaue N</author><author>Sumikawa K</author></authors>
<journal>The European journal of neuroscience</journal>
<volume>22</volume>
<number>4</number>
<page>845-60</page>
<abstract>Nicotine facilitates the induction of long-term potentiation (LTP) in the hippocampal CA1 region. The present study reveals the potential mechanisms underlying this effect of nicotine. Timed ACh-mediated activation of alpha7 nicotinic acetylcholine receptors (nAChRs) on pyramidal cells is known to promote LTP induction. Nicotine could suppress this timing-dependent mechanism by desensitizing nAChRs. Timed ACh-mediated activation of alpha7 nAChRs on feedforward interneurons can prevent LTP induction by inhibiting pyramidal cells. Nicotine diminished this ACh-mediated inhibition by desensitizing alpha7 nAChRs, thereby reducing the inhibitory influence on pyramidal cells. In addition to these desensitizing effects, nicotine activated presynaptic non-alpha7 nAChRs on feedforward interneurons to decrease the evoked release of gamma-aminobutyric acid (GABA) onto pyramidal cells. Furthermore, nicotine increased the frequency of spontaneous inhibitory postsynaptic currents (IPSCs) in pyramidal cells, and concomitantly caused a reduction in the size of responses to focal GABA application onto the dendrites of pyramidal cells, suggesting that the nicotine-induced increase in interneuronal activity leads ultimately to a use-dependent depression of evoked IPSCs in pyramidal cells. These nicotine-induced suppressions of inhibition of pyramidal cells were accompanied by enhanced N-methyl-D-aspartate (NMDA) responses in pyramidal cells. Thus, our results suggest that nicotine promotes the induction of LTP by diminishing inhibitory influences on NMDA responses while suppressing the ACh-mediated mechanisms. These ACh-independent mechanisms probably contribute to the nicotine-induced cognitive enhancement observed in the presence of cholinergic deficits, such as those in Alzheimer&#039;s disease patients.</abstract>
<pubmed_id>16115208</pubmed_id>
</detail>
</item>
